The afternoon session will cover:

1:30 pm - Monday 8th March 2027

  • Understanding the biological principles of ADCs and selecting the most appropriate target and antibody format
  • Analysing the key choices, trade-offs, and design considerations across the ADC chemistry toolbox
  • Evaluating preclinical in vivo efficacy data and the critical factors that inform successful ADC development and translation to the clinic